Traditional bone grafting relies upon the incorporation of a bone-cell bearing structure into a recipient site. The graft serves as a scaffold that is eventually replaced and remodeled. This process is known as osteoconduction. Recombinant human bone morphogenetic protein-2 (rhBMP-2) is commercially available as an acellular implant in which the protein is bound to an absorbable collagen sponge (ACS). The rhBMP-2/ACS implant converts undifferentiated mesenchymal stem cells into osteoblasts and promotes an intense local neovascular response. This process, known as osteoinduction, produces bone via membranous, chondroid, or endochondral ossification. The type of bone synthesis depends upon the mesenchymal substrate and the local cellular environment. Using this simple technique, bone defects can be resynthesized with good outcomes and a significant reduction in donor site morbidity. Repair of a critical-sized mandibular resection defect with ISO is described. Basic science concepts of rhBMP-2, relevant histopathologic findings, and clinical application are described.
B
one replacement in reconstructive surgery remains a challenge. Vascularized bone flaps such as rib, scapula, fibula, or iliac crest leave painful and deforming donor sites. Free grafts are limited by blood supply issues at the recipient site. The ideal technique would be one that would not depend upon microvascular transfer, would recruit cells at the donor site, and would be size independent. Bone substitutes such as hydroxyapatite are not helpful because they depend upon time-consuming processes of osteoconduction and creeping substitution. An ideal approach would involve implantation of inert, absorbable materials accompanied by powerful molecular signals capable of inducing bone formation from surrounding mesenchymal cells. The authors term such a process in situ osteogenesis (ISO).
Recombinant human bone morphogenetic protein-2 (rhBMP-2) is now commercially available in a purified form of standardized concentration. Application of rhBMP-2 to a Helistat (Integra Life Sciences, Plainsboro, NJ) absorbable collagen sponge in a standardized manner creates an implant into which cells can migrate, proliferate, and differentiate. The dosage of BMP-2 is highly species specific. Humans require the highest concentration, 1.5 mg/mL. Thus, an rhBMP-2/ACS implant will function reliably in other, less demanding animal systems, including dogs, pigs, rodents, and primates.
The bulk of preclinical work with BMP has concentrated on bones of interest to the orthopedic surgeon (ie, the axial skeleton below the skull and the appendicular skeleton of the extremities). The embryonic origin of vertebrae and ribs is from paraxial mesoderm. These bones are somite derivatives, in pairs. At every level, each vertebra and rib develop from the caudal half of the more cranial-level somite, and the rostral half of the somite at that level. Thus the third thoracic vertebra is formed from caudal second thoracic somite (#14) and rostral third thoracic somite (#15). The tubular bones of the appendicular skeleton develop differently, being formed from multiple levels of lateral plate mesoderm outside the somite system. [1] [2] All these bones, as well as those of the skull base (occipital somite derivatives), develop via chondral ossification. [3] [4] [5] The membranous bones of the facial skeleton are a different story. The mesenchymal origin of these bones is from neural crest cells, not mesoderm. Facial bones develop within a periosteal environment directly via membranous ossification. In some instances (the less wing of sphenoid) neural crest mesenchyme condenses first to cartilage and is then transformed into membranous bone. This little-known process is called chondroid ossification. 6 Histologic studies of bone created by distraction osteogenesis demonstrate the presence of chondroid ossification in the distraction chamber. 7 We shall return to this important concept later.
The differentiation of neural fold cells into neural crest cells occurs as a response to BMP-4 signals from ectoderm outlying the neural tube. 8 All neural crest cells consequently possess membrane-bound BMP receptors. [9] [10] [11] Thus, it is logical that stimulation of periosteum with rhBMP-2 will result in bone formation. Preclinical work testing the applications of ISO to oral surgery has been promising. Boyne documented the ability of rhBMP-2 to augment the alveolar ridge, fill the maxillary sinus, and replace surgically created mandibular defects. Using similar methodology he demonstrated that an rhBMP-2 implant was capable of repairing simulated cleft palate defects. [12] [13] [14] [15] Porcine calvarial defects also have been resynthesized. 16 Conventional bone grafts provide a ''scaffold'' that is eventually overtaken by native cells. This process is termed osteoconduction. Because free bone grafts initially have no blood supply, some degree of graft loss occurs. This places finite limits on how large a defect may be successfully grafted. In critical-size defects, the current approach to this dilemma relies on microsurgical transfer of vascularized bone. Freeflap procedures are inevitably complex, frequently lengthy, require intensive postoperative monitoring, and have a small, but finite, incident of flap loss. For these reasons, reconstruction of relatively common maxillofacial defects may lie beyond the capabilities of district hospitals, despite the technical abilities of the staff.
The mechanism of ISO is biologically distinct; it takes place via osteoinduction. When implanted into a periosteal chamber, rhBMP-2/ACS stimulates all areas of the environment equally. Osteogenesis does not need to ''build'' up in any particular direction. The entire cambium layer is a cell source. 17 Resident mesenchymal stem cells have their own autogenous blood supply. Thus, osteoblast activity and subsequent bone formation take place independently from the dimensions of the defect. ISO can potentially change the clinical management of critical size bone deficits.
This article describes the regeneration of a surgically created mandibular defect of critical size using rhBMP-2-mediated ISO. Because of its long-standing usage in wound healing, a porcine model is used. The clinical behavior of the rhBMP-2/ACS implant is documented. The histopathologic findings of ISO are described in detail. Discussion of the case centers on how the mechanism of action of rhBMP-2 is particularly relevant for facial bone reconstruction. Potential clinical applications of ISO are presented.
MATERIALS AND METHODS

T
he experimental protocol using current standards of animal safety was reviewed and accepted by the animal rights committee at Covance Surgical Laboratory (Berkeley, CA). An adolescent Yorkshire pig was chosen because of its known growth characteristics. With the pig under general anesthesia, the right mandible was exposed using a modified Risdon incision. A reconstruction plate was shaped, applied, and removed. Subperiosteal osteotomy was then performed, creating a trapezoidal defect 10 cm in length from the mandibular body. Continuity of the jaw was re-established with the reconstruction plate. Implantation of rhBMP-2 into the periosteal chamber was then performed.
Purified rhBMP-2 (Genetics Institute, Cambridge, MA) was reconstituted as two vials of 8.4 mL each. At a concentration of 1.5 mg/mL, the total dose was 12.6 mg. The protein was then applied uniformly to two Helistat absorbable collagen sponges (ACS) 4 cm 3 3 cm in dimension. Binding time was 20 minutes. The rhBMP-2/ACS implants were placed into the periosteal pocket at the osteotomy site. Using 2-mm absorbable Lactosorb (Walter Lorenz, Jacksonville, FL) screws, the implant was affixed by securing the reconstruction plate through the pilot holes previously drilled on mandible body at both sides of the trapezoidal defect. The periosteum was subsequently advanced over the reconstruction plate and sutured with 4-0 Vicryl. Soft tissue closure was carried out using 3-0 and 4-0 to the investing fascia and superficial fascia, respectively; 4-0 PDS was placed in running subcuticular fashion, followed by 4-0 nylon interrupted to the external surface. Given the unusual THE JOURNAL OF CRANIOFACIAL SURGERY / VOLUME 16, NUMBER 6 November 2005 pattern of wound healing that ensued, these details may be of some importance.
After an uneventful convalescence, the animal demonstrated normal function and jaw growth. Radiographs were taken of the jaw at monthly intervals. At 3 months, the animal was euthanized by intravenous injection. The right mandible was removed, cleaned of soft tissue to the level of the periosteum, fixed in 70% ethanol, and sent to Wyeth Bone Research Laboratory in Cambridge, Massachusetts.
Before histological processing, X-ray imaging was performed on the pig mandible. Because of the huge size (25 cm 3 12 cm 3 3.5 cm) of the pig mandible, multiple holes (2 mm diameter) were drilled into bone marrow to allow solution penetration to obtain the best quality during histologic processing. The entire right mandible was dehydrated in ascending gradient of alcohol (cleared in xylene) under vacuum and gentle agitation in the Fisher LX 120 Automatic Tissue Processor. Under 4°C, the mandible was immersed in liquid methyl methacrylate for infiltration and polymerization during a 1-month period. After completion of polymerization, the plastic block embedded with mandible was sectioned using a Riechert Jung Polycut. Eight-micron thick sections were cut at multiple levels, with 500 microns between levels. Sections were stretched and pressed on gelatin chromealum slides and placed in an oven at 45°C to 50°C overnight to ensure tissue adherence. Sections were then deplasticized, stained with Goldner's trichrome, and mounted with a coverslip. Under different magnification of objective lenses, qualitative evaluation of the sections was performed.
RESULTS
A t the time of surgical exposure, complete consolidation of the defect was noted. The newly formed bone respected the confines of the periosteal envelope. No ectopic bone was found external to the periosteum. The periosteal layer was incised and reflected. In situ osteogenesis was complete across the defect; the periosteal chamber was completely filled with no ''skip areas.'' Bone formation extended through the holes in the plate to reach lateral confines of the periosteal pocket. The plate itself was buried (ie, the interface zone between the lateral margin of the plate and the periosteum had also formed bone).
Radiographs demonstrated a progression of ossification within the surgical defect. At 30 days, a faint haziness was noted. By 60 days, definite, but nonuniform, ossification was present. At 90 days, complete ossification was present.
X-ray image and Goldner's trichrome stained histologic image (Fig 1) of the mandible both reveal that the 10-cm trapezoidal defect between the two screw holes (arrows) was filled completely with radiopaque bony tissues, with the exception of two small regions (regions 1 and 2). Heterotopic bone formation (H) occurred on the periosteal surface where rhBMP-2 leaked from one of the screw holes. In areas between and below regions 1 and 2, newly formed bone is consolidating into a solid cortical region to rebuild the posterior wall of the mandibular foramen (W). In area posterior to the region 1, newly formed bone spicules are connected to form a trabecular network, regenerating a new metaphyseal region of the posterior mandibular body. Regions 1 and 2 appear to be incompletely filled defect areas, within which residual ACS and mesenchymal stroma are observed in the center and ingrown osteoblastic new bone formation is visible on the periphery to completely fill the regions eventually.
Under the polarized lens, all bone tissue within the defect region appears to be immature woven bone (Fig 2, A and C) compared with mature lamellar bone observed outside of the defect; as such, the arrangement of interwoven coarse collagen fibers and the distribution of osteocytes are both in a random fashion (Fig 2, B and D) . In the periphery of the defect, where bone was regenerated earlier, bone tissue appears to be increasingly mature, as indicated by the replacement of woven bone by lamellar bone through the remodeling process. In these regions, lamellar bone packets are observed on the trabecular surface (Fig 2b) , and a Haversian system (H) with multiple layers of concentric lamellas is observed in the cortical region (Fig 2D) .
In regions 1 and 2, a typical process of membranous ossification can be clearly visualized step by step under the transmitted microscope (Figs 3 and 4) . Because of the rhBMP2-induced chemotactic effects, concentrated mesenchymal stromal cells (MSC) are observed around the residual ACS. These stromal cells differentiated into spindle-shaped preosteoblasts (or osteoblastic precursors; pOb), proliferated to increase cell number, consolidated into a preosteoblastic cluster, completely differentiated into osteoblasts, synthesized and released osteoid, and formed many nonmineralized trabeculae (Tb). This BMP-2, implant-induced cascade of ISO processes maintains is its momentum until the entire defect is filled with woven bone. Soon after the defect is filled completely by woven bone, the remodeling process occurs to remove the woven bone and replace it with lamellar bone in both the trabecular and cortical regions (Fig 5) .
In regions outside of the defect, native bone tissue appears to be mature lamellar bone under the polarized lens (Fig 2, B and D) . Lamellar bone demonstrates alternating light-dark layers, representing the parallel arrangement for each layer and the perpendicular arrangement between neighboring layers of collagen fibers. In this region, most bone surface is actively forming appositional bone because of the BMP-2-induced osteoconductive effect. Thus, a thick layer of osteoid is visible in most of the trabecular surface (Fig 6) .
DISCUSSION
Chemistry and Mechanism of Action of rhBMP-2/ACS R ecombinant human bone morphogenetic protein is a glycosylated dimer. 18 It binds onto specific membrane-bound receptors of mesenchymal cells causing them to differentiate into cartilage-forming, bone-forming, or even fat-forming cells. 19 The choice of which pathway a given MSC will take depends upon the presence of co-factors in the surrounding environment. For example, insulin, TGB 1, and ascorbic acid signal work together with BMP-2 to produce a chondrocytic lineage. 20 Bone morphogenetic proteins (BMPs) belong to the transforming growth factor beta superfamily. At least 20 human BMPs have been identified. BMPs are involved in embryogenesis and skeletal formation. BMPs are osteogenic proteins; that is, they have the ability to induce/initiate bone formation by attracting and binding to mesenchymal stem cells (MSCs). When MSCs are thus stimulated, they become bone-forming cells (osteoblasts). Bone may be formed via three pathways: (1) directly (intramembranous); (2) directly via a transient cartilage The amount and density of bone induced within a target site depends upon the initial concentration of rhBMP-2 at the site and the residence time the rhBMP-2 remains present at the site. Preclinical studies show that when rhBMP-2 is administered intravenously, it is cleared from the systemic circulation in a matter of minutes, being redistributed to the liver and reticuloendothelial system, and subsequently being excreted in the urine within 24 hours. 17 For this reason, in order for rhBMP-2 to have an appropriate residence time at the target site, it must be applied to an appropriate biodegradable carrier. Residual ACS is located in the central region (left); surrounding it is a stromal zone (Stroma) that is concentrated with dense mesenchymal stromal cells MSC. These MSC differentiate into preosteoblasts or osteoblastic precursors (pOb), which further proliferate to increase its number and consolidate into a osteoblastic cluster, where they synthesize type I collagen matrix, which is later mineralized into woven bone trabecula. When more woven bone spicules are generated, they connect to each other and form a woven trabecular bone network (WTb, midportion of the image), which, replaced by lamellar trabecular, becomes a partial lamellar trabecular bone network (LTb) on the right of the image. Under polarized light, collagen fiber of woven trabecular bone appears disorganized, whereas that of partial lamellar trabecular bone shows organized fiber orientation on the surface of the trabeculae. Fig 3 (20 3 objective lens) . MSC have now differentiated into preosteoblasts (pOb). The pOb cells have proliferated and consolidated into an osteoblastic cluster (Ob cluster). In the Ob cluster, the consolidated osteoblasts are just about to form a woven osteoid trabecula by synthesis of type I collagen matrix. Woven osteoid trabecula later becomes mineralized into woven trabecula.
Fig 5
Microphotograph represents the process of bone remodeling. In the center there are a group of cells working together to reshape a piece of bone. Originally the entire bone was solid woven cortical bone. Osteoclasts (Oc) start to remove the bone from right to left, resulting in a resorption cavity. After resorption, osteoblasts refill the cavity with osteoid (O), which later mineralizes into a lamellar Haversian system. Helistat, an implantable collagen sponge long in use as a hemostatic device for dental extraction sites, binds rhBMP-2 within 15 to 20 minutes. 21 These authors recommend 45 minutes of binding. Implantation should be carried out within 2 hours of reconstitution.
Optimal bone induction depends upon the concentration of rhBMP-2. This follows a species-specific gradient (rodents , dogs , nonhuman primates , humans). The optimal human dose is 1.5 mg/mL. MSCs from the surrounding environment invade the matrix. Degradation of the matrix occurs concomitant with formation of cartilage or woven bone (or both). Intense vascular ingrowth also occurs. With time, bone formation extends from the periphery of the implant toward its center until the implant is completely replaced by trabecular bone. Subsequent remodeling of the newly formed bone takes the place according to the physiology of the site. Thus, osteoinduction takes place at the surface of the implant. In conclusion: the local concentration of rhBMP-2 (expressed as mg rhBMP-2 per unit volume of matrix) is a more relevant concept than that of total local dosage.
The mechanism of rhBMP-2/ACS involves six steps. 18 They are: (1) Implantation: the surgical creation and/or modification of a environment containing mesenchymal stem cells. This involves contact with periosteum, muscle, or bone marrow; (2) Chemotaxis: MSCs from as much as 2 inches away are attracted by rhBMP-2 to the implantation site; (3) Proliferation: rhBMP-2/ACS implant provides a local environment where MSCs can multiply before differentiation; (4) Differentiation: rhBMP-2 binds to specific receptors on MSC cell surface causing them to change into osteoblasts; (5) Bone formation and angiogenesis: osteoblasts respond to local mechanical forces to produce osteoid. Intense new blood vessel formation is observed; and (6) Remodeling: bone remodels in response to local environment and mechanical forces.
Clinical performance of rhBMP-2/ACS is relatively predictable. The amount of bone produced relates to the size of the regenerate chamber. Complete filling of the regeneration chamber with the sponge is important. In spinal fusion, physical stability is provided by the transverse processes. The presence of an external container, either of absorbable PGA/PGL mesh or titanium crib/cage has proven useful in providing a shape to the regenerate bone. Serial computed tomography scan provides evidence of the time course of ISO. At 6 weeks, bone formation is clearly seen. By 12 weeks, consolidation is present. Critical size defects in porcine calvaria demonstrate identical histologic findings and tensile strength compared with the control side at 12 weeks. 16 Humans may lag behind, but evidence for this remains preliminary. Final remodeling can be considered complete at 24 weeks. This seems to an appropriate time for plate removal or additional manipulations, such as osteotomies for distraction.
The clinical behavior of soft tissues in the presence of an rhBMP-2 implant varies considerably from other surgical models. The intense vascular influx causes swelling to peak more slowly (2 days) and disappear more slowly (5 days) than the normal course of events. Wound healing is affected in an unknown manner. Scar formation above an implantation site seems to bypass some of the typical early stages. Scars at 1 month may have the clinical appearance of scars 6 to 12 months old.
The ISO Regeneration Chamber
The amount of rhBMP/ACS required for a given defect is volumetric. The implant should replace the defect milliliter for milliliter. In the experimental protocol, we prepared the ACS by rolling it up into a tube and suturing it with 5-0 chromic. Two such ''sushi rolls'' fit the defect nicely. Now available commercially as InfuseÒ bone graft (Medtronic Sofamor Danek, Memphis, TN), rhBMP-2/ACS is distributed in three sizes. Implant size can be augmented using absorbable granules of 85% hydroxyapatite and 15% calcium triphosphate (Mastergraft, from the same company). Because the dose of rhBMP-2 is supraphysiologic, volumetric expansion of the implant probably is both rational and efficient.
Mesenchymal stem cells undergo considerable migration to populate the implant scaffolding. Cellular migration within the regeneration chamber is the key element. The lattice-like structure of the implant facilitates this process. Physical abutment of a stainless steel reconstruction plate against the periosteal membrane was not sufficient to prevent bone formation at the interface.
The biologic processes involved in ISO for neural crest bone of periosteal origin differ in several key aspects for ISO of the long bones. Periosteal neural crest cells differentiate into membranous bone readily under rhBMP-2 stimulus. Formation of chondral bone in the extremities is a more lengthy process. Bone produced in this manner has a slower onset. Radiologic evidence mandibular mineralization is present at 10 days, whereas initial visualization in tibia occurs at 25 days or later. 22, 23 The histologic environment of endochondral bone is distinct from that of membranous bone. Periosteum surrounding long bones is not a ''template.'' Instead, cells must be recruited from surrounding muscle and soft tissues not in direct apposition to bone. Proliferation is also slower because it starts with fewer cells. Differentiation also requires a much longer time.
Membranous bone formation correlates with vascular density. Because of an abundant blood supply, facial soft tissues are very sensitive to BMP-2. ISO from this substrate occurs rapidly; this favors membranous over chondral bone formation. The effective dosage of rhBMP-2 may also influence membranous ossification. Low doses produce cartilage that is subsequently turned into bone, whereas larger doses lead to earlier ossification. At high concentration, BMP-2 induces direct (membranous) ossification. 24 Thus, the relative amount of endochondral versus membranous ossification is associated with the biology of the implantation site and the concentration of BMP-2 implanted.
Embryogenesis of Bone: Which Type to Make?
Bone develops from three mesenchymal cell sources: neural crest, paraxial mesoderm (PAM) via somitomeres and somites, and lateral plate mesoderm (LPM). The axial skeleton is formed as follows. Craniofacial membranous bone is almost exclusively derived from neural crest. Paraxial mesoderm forming just outside the neural tube also participates in skull formation. Beginning at the level of the notochord, PAM is organized into distinct segmental units called somitomeres (Sm), each one of which is associated with a unique corresponding developmental unit of the nervous system (neuromere). The first seven somitomeres do not form somites. Nonetheless, they give rise to the parietal bone (Sm 2 and Sm 3) and the temporal bone (Sm 6 and Sm 7). 4, 25, 26 Paraxial mesoderm at the level of the 8th to 11th somitomes becomes transformed into the four occipital somites, the sclerotomes of which undergo a complex process of fusion to form the basioccipital, exoccipital, and supraoccipital bones. 5 At the foramen magnum, the axial skeleton takes on a new organizational pattern, in which individual vertebrae arise as a fusion of two sclerotomes. This process is known as parasegmentation. Thus, the caudal fourth occipital somite combines with the cranial half of the first cervical somite (somite 5) to produce the proatlas. This ancient structure is incorporated into the skull as the occipitodental ligament and the cranial one third of the dens. In mouse embryos, application of retinoic acid causes a ''reshuffling'' of the parasegmentation process, in which the mysterious proatlas appears; the atlas and axis are converted to ''standard'' cervical vertebrae; and the total count of cervical vertebrae is eight. 27 The appendicular skeleton consists of the tubular bones of the extremities and their support platforms (the shoulder girdle and pelvis). These bones are not derived not from somitic sclerotomes. Instead, they arise as limb buds at junction zones of the somite system. In all embryos, limb buds develop at the cranial and caudal limits of the trunk. Lateral plate mesoderm is the cell source for these tubular bones. Parasegmentation is not involved. Instead, limb bones develop from LPM at multiple segmental levels. Coding of a limb bud is revealed by its sensory neuroanatomy. At each developmental level of the spinal cord (neuromere), a unique set of homeobox genes is expressed. This gene pattern is also expressed along the axis of the limb bud. 2, 28 Thus, the upper limb is assembled from LPM corresponding to neuromeric levels c5 to t1. This type of neuromeric ''coding'' system has also recently been applied to craniofacial bones. 10 The ''decision'' as to which type of bone an embryo will form may reduce down to a series of interactions between a mesenchymal substrate and the local environment. Mesenchymal cell membranes may differ in the density or sensitivity of BMP receptors. The relative concentration of BMP signals from surrounding tissues may also have a role. This, in turn, could be related to variations of local vascularity. Neural crest cells (bearing BMP receptors) also play a role in tissue vascularization because of elaboration of vascular endothelial growth factor (VEGF). 29 The Histologic Findings of the ISO Regenerate: Distraction Osteogenesis Explained?
Despite a large literature dedicated to its technical aspects, the biologic mechanisms of distraction osteogenesis (DO) remain poorly understood. 30, 31 DO initially was applied to chondral bones of the extracranial skeleton and later to membranous craniofacial bone. In the current study, histologic sections from the center of the specimen demonstrate two findings of relevance to the mechanism of DO. First, intact, unresorbed ACS at the center of the specimen was surrounded by osteoblasts producing osteoid. Thus, BMP-2 activity may be surprisingly long-lived, depending upon the integrity of the carrier. Wherever the BMP-2 signal is present, osteoblast activation will occur. The leading edge of the distractor exerts a local mechanical force on the periosteal membrane containing potentially responsive neural crest cells. Biologic activity of BMP-2 may thus ''follow'' the leading edge of the distractor.
Also present in the specimen were two distinct forms of ossification, membranous and chondroid. In normal craniofacial development, certain neural crest populations form intermediate cartilaginous structures that are subsequently transformed into membranous bone. The lesser wing of the sphenoid forms by chondroid ossification via the orbital cartilage. 3, 6 Chondroid ossification is a common factor linking DO with ISO. Histologic studies of bone produced by DO demonstrate the presence of cartilage. 7 Distraction regenerates have enhanced vascularity. 32, 33 Human osteoblasts respond to mechanical strain in a number of ways. 34 Production of bone matrix protein occurs independent of hormonal regulation. 35 Type I BMP receptors have been noted. 36 Expression of BMP mRNA in distraction-produced regenerates has been confirmed. 37, 38 Thus, we hypothesize that the biologic basis of DO and ISO involves a common molecular mechanism, using bone morphogenetic proteins as signaling intermediates.
The Clinical Potential of ISO in Craniofacial Surgery
ISO can be put to immediate use in many aspects of craniofacial surgery. First, it may be used to fill defects secondary to ablation or trauma. Children requiring calvarial bone can avoid donor site morbidity with rhBMP-2/ACS. In situations in which preshaped, fully formed bone is required, fullthickness calvarial bone may be harvested for grafts, put into place, and the full-thickness donor site reconstructed with confidence using rhBMP-2/ACS. This can be considered a ''BMP switch.'' Mandibular and maxillary defects resulting from clefts or resection can be reconstructed with the local periosteum as the cell source. In the case of clefts, wide subperiosteal undermining will permit transfer of adjacent periosteum into the cleft site. Mucoperiosteal transfer is the basis of the functional matrix cleft operation using the sliding sulcus technique.
Blast injuries or resections resulting in extensive periosteal loss necessitate cell source transfer from a distant source. Vascularized periosteum in extensive amounts can be harvested as a galeal-subgaleal fascia flap based on the superficial temporal artery. Access to the oral cavity can be achieved by tunneling it beneath the zygomatic arch and through the fat pad of Bichat. The flap remains viable even in the face of external carotid artery ligation because of back-fill from the internal carotid via the middle meningeal artery.
GSF-periosteum + rhBMP2 could provide a new form of reconstruction after cancer. Preclinical testing in all strains of tumor-bearing mice has failed to demonstrate any tumorigenic behavior of rhBMP-2. The safety of rhBMP-2 has been tested in 13 clinical studies involving 1000 enrolled patients with no increased risk of malignancy. Antibody formation to the type I bovine collagen of the carrier was not noted. 17 For example, hemimandibular defects could be treated using a reconstruction plate, importation of cell source, and osteoinductive agent implantation. Such a system could function in the face of postoperative irradiation. Radiotherapy can be initiated 6 weeks after surgery. Small-vessel damage takes effect approximately 6 weeks later. Within 12 weeks, mandibular resynthesis via ISO will be virtually complete. In selected patients at risk for extensive free-flap procedures, such as smokers or the elderly, ISO may prove a valuable option to reduce morbidity and hospital stays.
Existence of a genetically based segmentation system in the embryonic neural tube has brought a new understanding to head and neck development. 29, 39 Assembly of many common structures can be understood as craniofacial developmental fields. The physical confines of many of these fields may coincide with craniofacial bones. This model provides a highly effective surgical strategy for cleft reconstruction. 40, 41 Reconstruction of congenitally absent bone fields also is possible. Using distraction technology, an existing osseous structure can be used to expand surrounding soft tissues in a predetermined direction. A resulting periosteal ''pocket'' can be filled with rhBMP-2 to create a new bone structure. This would, in turn, maintain the newly expanded soft tissues in a stable configuration. An example of this would be the de novo synthesis of a missing mandibular ramus via expansion of a segment from the distal mandibular body. This method of reconstruction would logically be termed distractionassisted in situ osteogenesis (DISO).
SUMMARY N
eural crest mesenchymal stem cells form the membranous bones of the craniofacial skeleton. Residing in the periosteum, these cells possess BMP receptors. Implantation of rhBMP-2/ACS into a periosteal environment causes these cells to migrate, proliferate, and differentiate into osteoblasts. This results in a faithful reproduction of bone native to that specific environment. This process, in situ osteogenesis, occurs by osteoinduction, rather than osteoconduction. Because the rhBMP-2 implant causes a massive influx of vasculature, ISO does not follow the constraints of traditional free-grafting techniques. The shape and size of bone produced by ISO is dictated strictly by the biology of the envelope. Reconstruction using ISO is rapid, versatile, and biologically sound. New structures could be potentially synthesized using DISO.
